[Streptococcus pyogenes pathogenic factors]
1Université Paris-Diderot, PRES Sorbonne-Paris-Cité, 46, rue Henri-Huchard, 75018 Paris, France; Service de microbiologie, hôpital Robert-Debré (AP-HP), 48, boulevard Sérurier, 75019 Paris, France.
Abstract:
The pathogenicity of ß-hemolytic group A streptococcus (GAS) is particularly diverse, ranging from mild infections, such as pharyngitis or impetigo, to potentially debilitating poststreptococcal diseases, and up to severe invasive infections such as necrotizing fasciitis or the dreaded streptococcal toxic shock syndrome. This variety of clinical expressions, often radically different in individuals infected with the same strain, results from a complex interaction between the bacterial virulence factors, the mode of infection and the immune system of the host. Advances in comparative genomics have led to a better understanding of how, following this confrontation, GAS adapts to the immune system's pressure, either peacefully by reducing the expression of certain virulence factors to achieve an asymptomatic carriage, or on the contrary, by overexpressing them disproportionately, resulting in the most severe forms of invasive infection.
Insights
Group A Streptococcus (GAS) causes diverse infections due to complex interactions between bacterial factors and host immunity. GAS adapts to immune pressure, leading to asymptomatic carriage or severe invasive disease.
Area of Science:
- Microbiology
- Immunology
- Genomics
Context:
- Group A Streptococcus (GAS) exhibits varied pathogenicity, from mild pharyngitis to severe invasive infections like necrotizing fasciitis.
- Clinical manifestations differ significantly among individuals infected with the same GAS strain.
Purpose:
- To explore the complex interplay between bacterial virulence factors, infection dynamics, and host immune responses in determining GAS pathogenicity.
- To understand how GAS adapts to host immune pressure, influencing disease outcomes.
Summary:
- GAS pathogenicity is shaped by a dynamic interaction involving bacterial virulence factors and the host immune system.
- Comparative genomics reveals GAS strategies to evade or overcome host immunity, including downregulation for carriage or overexpression for invasive disease.
- The host's immune system plays a critical role in modulating the clinical outcome of GAS infections.
Impact:
- Provides insights into the molecular mechanisms underlying GAS pathogenesis and disease spectrum.
- Advances understanding of host-pathogen interactions in streptococcal infections.
- Informs potential therapeutic strategies targeting GAS virulence and host immune modulation.
Related Concept Videos
Staphylococcal Skin Infections
Gastritis II: Pathophysiology
Bacterial Toxins
Bacterial Meningitis II: Pathophysiology
Regulation of Bacterial Virulence
Colonisation of Pathogens


